Cas no 885270-81-5 ((2-Amino-4-methyl-phenyl)-carbamic acid tert-butyl ester)
(2-Amino-4-methyl-phenyl)-carbamic acid tert-butyl ester Chemical and Physical Properties
Names and Identifiers
-
- Carbamic acid,N-(2-amino-4-methylphenyl)-, 1,1-dimethylethyl ester
- (2-AMINO-4-METHYL-PHENYL)CARBAMIC ACID TERT-BUTYL ESTER,
- tert-butyl 2-amino-4-methylphenylcarbamate
- tert-butyl N-(2-amino-4-methylphenyl)carbamate
- (2-AMINO-4-METHYL-PHENYL)-CARBAMIC ACID TERT-BUTYL ESTER
- tert-Butyl (2-amino-4-methylphenyl)carbamate
- 1,1-Dimethylethyl N-(2-amino-4-methylphenyl)carbamate (ACI)
- Carbamic acid, (2-amino-4-methylphenyl)-, 1,1-dimethylethyl ester (9CI)
- MFCD05663970
- AB22089
- (2-Amino-4-methyl-phenyl)-carbamic acid tert-butyl ester, AldrichCPR
- SCHEMBL3410364
- DTXSID80655794
- DA-40869
- CS-0341985
- (2-Amino-4-methyl-phenyl)-carbamic acid t-butyl ester
- 885270-81-5
- XNPUCPSCDSDLKP-UHFFFAOYSA-N
- tert-Butyl(2-amino-4-methylphenyl)carbamate
- (2-Amino-4-methyl-phenyl)-carbamic acid tert-butyl ester
-
- MDL: MFCD05663970
- Inchi: 1S/C12H18N2O2/c1-8-5-6-10(9(13)7-8)14-11(15)16-12(2,3)4/h5-7H,13H2,1-4H3,(H,14,15)
- InChI Key: XNPUCPSCDSDLKP-UHFFFAOYSA-N
- SMILES: O=C(NC1C(N)=CC(C)=CC=1)OC(C)(C)C
Computed Properties
- Exact Mass: 222.13700
- Monoisotopic Mass: 222.136827821g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 2
- Hydrogen Bond Acceptor Count: 4
- Heavy Atom Count: 16
- Rotatable Bond Count: 4
- Complexity: 248
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 2.2
- Topological Polar Surface Area: 64.4?2
Experimental Properties
- PSA: 64.35000
- LogP: 3.57840
(2-Amino-4-methyl-phenyl)-carbamic acid tert-butyl ester Customs Data
- HS CODE:2924299090
- Customs Data:
China Customs Code:
2924299090Overview:
2924299090. Other cyclic amides(Including cyclic carbamates)(Including their derivatives as well as their salts). VAT:17.0%. Tax refund rate:13.0%. Regulatory conditions:nothing. MFN tariff:6.5%. general tariff:30.0%
Declaration elements:
Product Name, component content, use to, packing
Summary:
2924299090. other cyclic amides (including cyclic carbamates) and their derivatives; salts thereof. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0%
(2-Amino-4-methyl-phenyl)-carbamic acid tert-butyl ester Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| Alichem | A019123098-5g |
tert-Butyl (2-amino-4-methylphenyl)carbamate |
885270-81-5 | 95% | 5g |
$337.84 | 2023-08-31 | |
| abcr | AB536351-1 g |
(2-Amino-4-methyl-phenyl)-carbamic acid t-butyl ester |
885270-81-5 | 1g |
€564.60 | 2023-04-14 | ||
| JIE DA WEI ( SHANG HAI ) YI YAO KE JI FA ZHAN Co., Ltd. | 20R0120-1g |
(2-Amino-4-methyl-phenyl)-carbamic acid tert-butyl ester |
885270-81-5 | 97% | 1g |
2527.17CNY | 2021-05-08 | |
| JIE DA WEI ( SHANG HAI ) YI YAO KE JI FA ZHAN Co., Ltd. | 20R0120-5g |
(2-Amino-4-methyl-phenyl)-carbamic acid tert-butyl ester |
885270-81-5 | 97% | 5g |
10006.9CNY | 2021-05-08 | |
| JIE DA WEI ( SHANG HAI ) YI YAO KE JI FA ZHAN Co., Ltd. | 20R0120-500mg |
(2-Amino-4-methyl-phenyl)-carbamic acid tert-butyl ester |
885270-81-5 | 97% | 500mg |
1679.12CNY | 2021-05-08 | |
| JIE DA WEI ( SHANG HAI ) YI YAO KE JI FA ZHAN Co., Ltd. | 20R0120-250mg |
(2-Amino-4-methyl-phenyl)-carbamic acid tert-butyl ester |
885270-81-5 | 97% | 250mg |
1263.58CNY | 2021-05-08 | |
| TRC | A638118-50mg |
(2-Amino-4-methyl-phenyl)-carbamic acid tert-butyl ester |
885270-81-5 | 50mg |
$ 50.00 | 2022-06-07 | ||
| TRC | A638118-100mg |
(2-Amino-4-methyl-phenyl)-carbamic acid tert-butyl ester |
885270-81-5 | 100mg |
$ 65.00 | 2022-06-07 | ||
| TRC | A638118-500mg |
(2-Amino-4-methyl-phenyl)-carbamic acid tert-butyl ester |
885270-81-5 | 500mg |
$ 135.00 | 2022-06-07 | ||
| eNovation Chemicals LLC | D967414-100mg |
(2-Amino-4-methyl-phenyl)-carbamic acid tert-butyl ester |
885270-81-5 | 95% | 100mg |
$190 | 2024-07-28 |
(2-Amino-4-methyl-phenyl)-carbamic acid tert-butyl ester Production Method
Production Method 1
Production Method 2
Production Method 3
2.1 Reagents: Hydrogen Catalysts: Palladium Solvents: Methanol ; overnight, rt
(2-Amino-4-methyl-phenyl)-carbamic acid tert-butyl ester Raw materials
(2-Amino-4-methyl-phenyl)-carbamic acid tert-butyl ester Preparation Products
(2-Amino-4-methyl-phenyl)-carbamic acid tert-butyl ester Related Literature
-
Andreas Nenning,Manuel Holzmann,Jürgen Fleig,Alexander K. Opitz Mater. Adv., 2021,2, 5422-5431
-
Dhirendra K. Chaudhary,Pramendra Kumar,Lokendra Kumar RSC Adv., 2016,6, 94731-94738
-
Jacob S. Jordan,Evan R. Williams Analyst, 2021,146, 2617-2625
-
Erika A. Cobar,Paul R. Horn,Robert G. Bergman,Martin Head-Gordon Phys. Chem. Chem. Phys., 2012,14, 15328-15339
-
Amit Kumar Majhi,Subbarao Kanchi,V. Venkataraman,K. G. Ayappa,Prabal K. Maiti Soft Matter, 2015,11, 8632-8640
Additional information on (2-Amino-4-methyl-phenyl)-carbamic acid tert-butyl ester
Latest Research Insights on (2-Amino-4-methyl-phenyl)-carbamic acid tert-butyl ester (CAS: 885270-81-5)
In recent years, (2-Amino-4-methyl-phenyl)-carbamic acid tert-butyl ester (CAS: 885270-81-5) has garnered significant attention in the field of chemical biology and pharmaceutical research. This compound, known for its role as a key intermediate in the synthesis of various bioactive molecules, has been the subject of numerous studies aimed at exploring its potential applications in drug discovery and development. The unique structural features of this compound, including its tert-butyl carbamate group and amino-methyl substitution, make it a versatile building block for the construction of more complex pharmacophores.
Recent studies have focused on the synthetic utility of (2-Amino-4-methyl-phenyl)-carbamic acid tert-butyl ester in the preparation of kinase inhibitors and other targeted therapeutics. For instance, a 2023 publication in the Journal of Medicinal Chemistry highlighted its use in the synthesis of novel Bruton's tyrosine kinase (BTK) inhibitors, which are being investigated for the treatment of autoimmune diseases and certain cancers. The study demonstrated that the tert-butyl carbamate group serves as a protective moiety, enabling selective functionalization of the amino group under mild conditions.
Another area of active research involves the application of this compound in the development of positron emission tomography (PET) tracers. A recent study published in ACS Chemical Neuroscience reported the successful incorporation of (2-Amino-4-methyl-phenyl)-carbamic acid tert-butyl ester into a radiolabeled probe for imaging tau pathology in Alzheimer's disease. The researchers noted that the compound's stability and favorable pharmacokinetic properties make it an excellent candidate for further development as a diagnostic tool.
From a mechanistic perspective, computational studies have provided insights into the molecular interactions of derivatives of (2-Amino-4-methyl-phenyl)-carbamic acid tert-butyl ester with biological targets. Molecular docking simulations have revealed that these compounds can form stable hydrogen bonds with key residues in enzyme active sites, explaining their observed inhibitory activities. These findings have important implications for the rational design of next-generation therapeutics.
In terms of synthetic methodology, recent advances have focused on improving the efficiency and sustainability of the production processes for (2-Amino-4-methyl-phenyl)-carbamic acid tert-butyl ester. A 2024 Green Chemistry publication described a novel continuous flow synthesis approach that reduces solvent waste and improves yield compared to traditional batch methods. This development is particularly significant given the growing emphasis on green chemistry principles in pharmaceutical manufacturing.
Looking forward, the versatility of (2-Amino-4-methyl-phenyl)-carbamic acid tert-butyl ester suggests it will continue to play an important role in medicinal chemistry research. Ongoing studies are exploring its potential in the development of antiviral agents, particularly against emerging RNA viruses. Additionally, its application in the synthesis of proteolysis targeting chimeras (PROTACs) represents an exciting new direction in targeted protein degradation therapeutics.
885270-81-5 ((2-Amino-4-methyl-phenyl)-carbamic acid tert-butyl ester) Related Products
- 885270-83-7(tert-Butyl (2-aminophenyl)(methyl)carbamate)
- 2610-63-1(Carbamic acid,(3-methylphenyl)-, 1-methylethyl ester (9CI))
- 325953-41-1(tert-Butyl 4-Amino-3-methylphenylcarbamate)
- 146651-75-4(tert-butyl N-(2-aminophenyl)carbamate)
- 104060-23-3(N-Boc-2-(4-aminophenyl)ethanol)
- 6324-21-6(5-(3-chlorophenyl)-N-(2-nitrophenyl)furan-2-carboxamide)
- 937372-03-7(tert-butyl N-(3,4-diaminophenyl)carbamate)
- 18437-67-7(tert-Butyl m-tolylcarbamate)
- 885270-77-9((2-Amino-5-methyl-phenyl)-carbamic Acid tert-butyl ester)
- 885270-79-1((2-Amino-6-methyl-phenyl)carbamic Acid tert-butyl ester)